Abdulrahman H Almaeen
Overview
Explore the profile of Abdulrahman H Almaeen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
37
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Almaeen A, Saad-Eldien H, Gabr H
Int J Immunopathol Pharmacol
. 2025 Feb;
39:3946320251315007.
PMID: 39921228
Background: Mesenchymal stromal/stem cells (MSCs) have potent immunomodulatory abilities, particularly in a milieu of hyperactive immune system, through secreting a number of cytokines, growth factors, bioactive compounds and peptides, and...
2.
Saber S, Alamri M, Alfaifi J, Saleh L, Abdel-Ghany S, Aboregela A, et al.
Pharmaceuticals (Basel)
. 2025 Jan;
18(1.
PMID: 39861197
[...].
3.
Eldien H, Almaeen A, El Fath A, Taha A, Ahmed R, Elfadil H, et al.
Diagnostics (Basel)
. 2025 Jan;
15(2).
PMID: 39857114
COVID-19 has caused widespread morbidity and mortality, with its effects extending to multiple organ systems. Despite known risk factors for severe disease, including advanced age and underlying comorbidities, patient outcomes...
4.
Alsharif S, Gardouh A, Mandour M, Alaqais Z, Alharbi L, Almarwani M, et al.
Toxicol Mech Methods
. 2023 Dec;
34(4):385-397.
PMID: 38083807
Polymeric poly (lactic-co-glycolic acid) (PLGA)-lipid hybrid nanoparticles (PNPs)-based therapy are powerful carriers for various therapeutic agents. This study was conducted to evaluate the chemotherapeutic potential of free 5-flurouracil (5FU) and...
5.
Almaeen A, Abouelkheir M
Biomedicines
. 2023 Oct;
11(10).
PMID: 37893067
The currently available treatment for acute lymphoblastic leukemia (ALL) is mainly dependent on the combination of chemotherapy, steroids, and allogeneic stem cell transplantation. However, refractoriness and relapse (R/R) after initial...
6.
Al-Rasheedi A, Almaeen A, Alotaibi A, Alruwaili A, Alruwaili S, Alruwaili W, et al.
Int J Immunopathol Pharmacol
. 2023 Aug;
37:3946320231196745.
PMID: 37596741
Objectives: The balance between proinflammatory IFN-γ Th1 vs. the anti-inflammatory allergy-mediating IL-4-heralded Th2 reactions is pivotal in IgE-mediated allergic rhinitis (AR). Hypoxia-Inducible Factor (HIF)-1α is inducible by hypoxia and various...
7.
Saber S, Alamri M, Alfaifi J, Saleh L, Abdel-Ghany S, Aboregela A, et al.
Pharmaceuticals (Basel)
. 2023 Jul;
16(7.
PMID: 37513865
Ulcerative colitis is a chronic and incurable form of inflammatory bowel disease that can increase the risk of colitis-associated cancer and mortality. Limited treatment options are available for this condition,...
8.
Taha A, Alduraywish A, Almaeen A, El-Metwally T, Alayyaf M, Mallick A, et al.
Vaccines (Basel)
. 2023 Jan;
11(1).
PMID: 36679870
(1) Backgrounds and Objectives: The global battle to contain the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is still ongoing. This cross-sectional study aimed to detect the seroprevalence of anti-SARS-CoV-2 IgM/IgG among...
9.
Ghazy A, Almaeen A, Taher I, Alrasheedi A, Elsheredy A
Diagnostics (Basel)
. 2023 Jan;
13(2).
PMID: 36673116
Background: COVID-19 outcomes display multiple unexpected varieties, ranging from unnoticed symptomless infection to death, without any previous alarm or known aggravating factors. Aim: To appraise the impact of ACErs4291(A/T) and...
10.
Almaeen A, Alduraywish A, Ghazy A, El-Metwally T, Alayyaf M, Alrayes F, et al.
Int J Environ Res Public Health
. 2022 Jun;
19(12).
PMID: 35742368
(1) Backgrounds and Objectives: Since its discovery, information about the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has spread rapidly. However, many issues remain unresolved. Coronaviruses are primarily transmitted through respiratory secretions....